Influence of FSH/LH Ratio in Controlled Ovarian Stimulation
NCT ID: NCT02994550
Last Updated: 2022-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
447 participants
INTERVENTIONAL
2017-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimising FSH Dosage During in Vitro Fertilization Fertilization (IVF)
NCT02915900
The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.
NCT00334425
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
NCT02310919
Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients
NCT02293668
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
NCT01206803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FSH/LH 2/1
dose: 300IU FSHrec and 150IU LHrec
FSH/LH
FSH/LH 4/1
dose: 300IU FSHrec and 75IU LHrec
FSH/LH
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FSH/LH
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed IVF and cryopreservation informed consent.
* Age \>35 and \<40 years.
* FSH levels \<10 mIU/ml.
35 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Cruces
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonia Exposito
PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEIC E14/30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.